Etruscus Resources Corp. (the "Company" or "Etruscus") is pleased to report results from its 2025 diamond drill program at the Zappa Porphyry Target, a high-priority copper-gold porphyry prospect ...
Welcome back to our Tech Tip series! Today, we’ll review one of the most essential tools in every toolbox, a multimeter.
According to Mordor Intelligence, the cell therapy market is valued at USD 5.5 billion in 2025 and is projected to surpass USD 12.2 billion by 2030, advancing at an 17.05% CAGR, driven by rising ...
A new evidence brief, based on a study by the Juno Evidence Alliance conducted in collaboration with CABI's One Health Hub, has highlighted that a One Health approach is needed in research into ...
Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens, and adults ...
SquareX, the pioneer in Browser Detection and Response (BDR), announced its strategic partnership with Wipro Ventures, Wipro ...
Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...
Abstract By tapping into the iconography of a category of seventeenth-century still-life paintings, Poe has given us a “vanitas trilogy”—“King Pest,” “Amontillado,” and “The Masque of the Red Death,” ...
1 Commission free on all stocks and ETFs traded within a UK GBP GIA, ISA and SIPP account. Other fees may apply. 2 4.00% AER variable interest on GBP cash balances in GIA, ISA and SIPP accounts.
U.S. 3 Year Treasury Note-0.0170 3.4930% U.S. 5 Year Treasury Note-0.042 3.603% U.S. 7 Year Treasury Note-0.060 3.788% ...